Pricing Log in Create free account

Context Therapeutics Inc. (CNTX) vs Evaxion A/S - Sponsored ADR (EVAX)

Context Therapeutics Inc. and Evaxion A/S - Sponsored ADR are both Biotechnology companies. Context Therapeutics Inc. and Evaxion A/S - Sponsored ADR are of similar size ($23.4M and $22.1M). Across the 11 metrics below, Context Therapeutics Inc. leads on 6 and Evaxion A/S - Sponsored ADR on 5.

Valuation

Metric CNTX EVAX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.97 9.71
P/B 0.60 2.21 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 n/m 0.64
EV/Sales n/m 1.30 9.21
Earnings yield (200.00%) (34.28%) (33.15%)
Free cash flow yield (148.95%) (145.38%) (25.50%)

Profitability

Metric CNTX EVAX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.14%) (96.10%) (56.36%)
Return on assets (68.96%) (36.20%) (48.04%)
Return on invested capital 0.00% (245.79%) 0.00%

Growth

Metric CNTX EVAX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 17.39% 89.85% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTX EVAX Biotechnology median
Debt to equity 0.00 0.71 0.00
Current ratio 5.81 5.06 4.72
Net debt to EBITDA 1.66 1.87 0.96

Dividend

Metric CNTX EVAX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTX EVAX Biotechnology median
Market cap 22.09m 23.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack